Literature DB >> 20683777

Effects of memantine on convulsive reactions and the organization of sleep in krushinskii-molodkina rats with an inherited predisposition to audiogenic convulsions.

S I Vataev1, E P Zhabko, N Ya Lukomskaya, G A Oganesyan, L G Magazanik.   

Abstract

Krushinskii-Molodkina rats, which have a genetic predisposition to audiogenic convulsions, are used as a natural animal model for studies of the actions of anticonvulsants. It is important to understand the extent to which changes in glutamatergic synaptic transmission is involved in the mechanisms producing convulsive states and in the functional organization of the sleep-waking cycle in rats of this strain. The present report describes experiments addressing this, in which i.m. doses of 5 and 10 mg/kg of a noncompetitive NMDA glutamate receptor antagonist of the memantine type were given at different times (30 min, 1, 2, and 3 h) before presentation of sound stimuli (sine-wave tones at 8 kHz, 90 dB). Effects on the latent periods of the initial motor excitation, the appearance of clonic convulsions of different intensities, and, finally, tonic convulsions with limb and tail extension were evaluated. The greatest attenuation of convulsive seizures, to a level consisting only of motor excitation, was obtained in 60% of the rats between 1 and 2 h after administration. There were no differences between the effects of doses of 5 and 10 mg/kg. When doses were given 3 h before sound provocation, convulsive reactions became more marked than at 2 h, though they were nevertheless more marked than in controls. Krushinskii-Molodkina rats with chronically implanted electrodes for recording brain electrical activity were used to study the effects of memantine on the organization of sleep. These experiments showed that the rats' sleep during the first hour after dosage consisted only of short episodes of superficial slow-wave sleep, and that even this sleep disappeared completely 54.4 +/- 4.9 and 39.9 +/- 5.2 min after administration of the agent at doses of 5 and 7 mg/kg, respectively. Rats showed a complete absence of sleep for 2 and 2.5 h, respectively, after which episodes of slow-wave sleep reappeared. The first episodes of REM sleep was seen in rats only after 3.3 +/- 0.2 and 3.7 +/- 0.2 h after memantine injections. The appearance of these episodes provided evidence that the effects of memantine on the activity of the somnogenic system of the animals' brains were complete and that recovery of the normal organization of the sleep-waking cycle had started. The synchronicity and codirectionality of the blocking action of memantine on sleep organization and measures of audiogenic convulsions in Krushinskii-Molodkina rats is evidence for the involvement of glutamatergic synapses with NMDA receptors in both the regulation of the somnogenic systems and the pathogenesis of epileptiform manifestations in rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683777     DOI: 10.1007/s11055-010-9345-x

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  35 in total

1.  The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner.

Authors:  G Rammes; R Rupprecht; U Ferrari; W Zieglgänsberger; C G Parsons
Journal:  Neurosci Lett       Date:  2001-06-22       Impact factor: 3.046

Review 2.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

3.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

4.  Sleep patterns in congenital dopamine beta-hydroxylase deficiency.

Authors:  J H Tulen; A J Man in't Veld; K Mechelse; F Boomsma
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

5.  Sleep deficits in rats after NMDA receptor blockade.

Authors:  W S Stone; D L Walker; P E Gold
Journal:  Physiol Behav       Date:  1992-09

6.  [Role of NMDA and AMPA glutamate receptors in the mechanism of korazol-induced convulsions in mice].

Authors:  N Ia Lukomskaia; N I Rukoiatkina; L V Gorbunova; V E Gmiro; L G Magazanik
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2003-03

Review 7.  The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.

Authors:  Jaime M Monti; Héctor Jantos
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

8.  Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex.

Authors:  S Samnick; S Ametamey; K L Leenders; P Vontobel; G Quack; C G Parsons; H Neu; P A Schubiger
Journal:  Nucl Med Biol       Date:  1998-05       Impact factor: 2.408

9.  [Comparison of the anticonvulsant activity of organic mono- and di-cations and their potential to inhibit NMDA and AMPA glutamate receptors].

Authors:  N Ia Lukomskaia; N I Rukoiatkina; L V Gorbunova; V E Gmiro; K V Bol'shakov; L G Magazanik
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2002-09

10.  Distribution of memantine in brain, liver, and blood of the rat.

Authors:  W Wesemann; J D Schollmeyer; G Sturm
Journal:  Arzneimittelforschung       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.